Mirtazapine Tablet, Film Coated
Product Images NDC 17856-0101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 17856-0101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 0101 01)

Image Description (17856 0101 01)
Label for Mirtazapine 7.5 mg tablet, USP, film-coated, oral dosage form. The label shows the product NDC 17856-0101-01, quantity of 100 tablets, and instructions to see the package insert for indications and dosage. It includes storage instructions to keep at 25°C with controlled room temperature excursions permitted, and warns to keep out of reach of children. The label is from Atlantic Biologicals Corp., with a provided reorder phone number.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure of Mirtazapine, a compound consisting of interconnected aromatic rings and a methylated nitrogen atom, as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.